$434.73
-2.36-0.54%
At Close: -
$434.73
00.00%
After Hours: 4:00 PM EDT
15 minutes delayed
want to know what
the Bulls & Bears Say?
Northrop Grumman (NYSE:NOC) 주식, 분석가 평가, 목표 가격, 예측
Northrop Grumman Corp의 합의된 목표 주가는 65개의 최신 애널리스트 평가를 살펴보고 설정되었습니다. 마지막 3개의 애널리스트 평가는 6월 26, 2024, 6월 21, 2024 및 4월 30, 2024에 BTIG, Bernstein 및 Wells Fargo에서 발표되었습니다. BTIG, Bernstein 및 Wells Fargo 사이의 평균 목표 주가는 $520로, 이러한 3개의 애널리스트 평가에서 Northrop Grumman Corp에 대한 암시된 19.61% upside가 있습니다.
추천을 하는 애널리스트 회사들1
BTIG
Bernstein
Wells Fargo
RBC Capital
Susquehanna
1애널리스트 평가로부터 계산됨
Northrop Grumman에 대한 애널리스트 평점
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 06/26/2024 | Buy Now | 29.97% | BTIG | Andre Madrid | → $565 | Initiates | → Buy | Get Alert |
| 06/21/2024 | Buy Now | 9.72% | Bernstein | Douglas Harned | → $477 | Downgrade | Outperform → Market Perform | Get Alert |
| 04/30/2024 | Buy Now | 19.15% | Wells Fargo | Matthew Akers | $483 → $518 | Maintains | Equal-Weight | Get Alert |
| 04/26/2024 | Buy Now | 9.26% | RBC Capital | Ken Herbert | $450 → $475 | Maintains | Sector Perform | Get Alert |
| 04/26/2024 | Buy Now | 28.82% | Susquehanna | Charles Minervino | $540 → $560 | Maintains | Positive | Get Alert |
| 04/26/2024 | Buy Now | 16.16% | Baird | Peter Arment | $475 → $505 | Maintains | Neutral | Get Alert |
| 04/22/2024 | Buy Now | — | Alembic Global | Peter Skibitski | — | Upgrade | Neutral → Overweight | Get Alert |
| 01/26/2024 | Buy Now | 24.22% | Susquehanna | Charles Minervino | $560 → $540 | Maintains | Positive | Get Alert |
| 01/26/2024 | Buy Now | 9.26% | Baird | Peter Arment | $505 → $475 | Maintains | Neutral | Get Alert |
| 01/26/2024 | Buy Now | 3.51% | RBC Capital | Ken Herbert | $515 → $450 | Downgrade | Outperform → Sector Perform | Get Alert |
| 01/16/2024 | Buy Now | 16.16% | Baird | Peter Arment | → $505 | Downgrade | Outperform → Neutral | Get Alert |
| 12/15/2023 | Buy Now | 8.8% | Deutsche Bank | Scott Deuschle | $541 → $473 | Downgrade | Buy → Hold | Get Alert |
| 12/14/2023 | Buy Now | 3.51% | Wolfe Research | Myles Walton | → $450 | Downgrade | Peer Perform → Underperform | Get Alert |
| 10/31/2023 | Buy Now | 0.06% | JP Morgan | Seth Seifman | $430 → $435 | Maintains | Neutral | Get Alert |
| 10/11/2023 | Buy Now | 27.67% | UBS | Gavin Parsons | → $555 | Initiates | → Buy | Get Alert |
| 09/28/2023 | Buy Now | 15.47% | Deutsche Bank | Myles Walton | → $502 | Initiates | → Buy | Get Alert |
| 09/18/2023 | Buy Now | 0.06% | Wells Fargo | Sarah Akers | $485 → $435 | Maintains | Equal-Weight | Get Alert |
| 08/03/2023 | Buy Now | 15.01% | RBC Capital | Ken Herbert | → $500 | Reiterates | Outperform → Outperform | Get Alert |
| 07/31/2023 | Buy Now | 11.56% | Wells Fargo | Sarah Akers | $448 → $485 | Maintains | Equal-Weight | Get Alert |
| 07/28/2023 | Buy Now | 41.47% | B of A Securities | Ronald Epstein | $655 → $615 | Maintains | Buy | Get Alert |
| 07/28/2023 | Buy Now | 11.56% | Citigroup | Jason Gursky | $502 → $485 | Maintains | Neutral | Get Alert |
| 05/11/2023 | Buy Now | 3.51% | Barclays | David Strauss | $580 → $450 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 04/28/2023 | Buy Now | 15.47% | Citigroup | Jason Gursky | $488 → $502 | Maintains | Neutral | Get Alert |
| 04/28/2023 | Buy Now | 8.8% | Wells Fargo | Sarah Akers | $470 → $473 | Maintains | Equal-Weight | Get Alert |
| 02/06/2023 | Buy Now | 12.71% | Credit Suisse | Scott Deuschle | $500 → $490 | Maintains | Outperform | Get Alert |
| 01/31/2023 | Buy Now | 8.11% | Wells Fargo | Matthew Akers | $460 → $470 | Maintains | Equal-Weight | Get Alert |
| 01/27/2023 | Buy Now | 12.25% | Citigroup | Jason Gursky | $544 → $488 | Maintains | Neutral | Get Alert |
| 01/27/2023 | Buy Now | 38.25% | Morgan Stanley | Kristine Liwag | $626 → $601 | Maintains | Overweight | Get Alert |
| 01/27/2023 | Buy Now | -7.99% | JP Morgan | Seth Seifman | $465 → $400 | Maintains | Neutral | Get Alert |
| 01/27/2023 | Buy Now | — | Wolfe Research | Myles Walton | — | Downgrade | Outperform → Peer Perform | Get Alert |
| 01/27/2023 | Buy Now | 19.61% | RBC Capital | Ken Herbert | $550 → $520 | Maintains | Outperform | Get Alert |
| 01/27/2023 | Buy Now | 23.06% | Susquehanna | Charles Minervino | $615 → $535 | Maintains | Positive | Get Alert |
| 01/27/2023 | Buy Now | 15.01% | Credit Suisse | Scott Deuschle | $540 → $500 | Maintains | Outperform | Get Alert |
| 01/27/2023 | Buy Now | 9.95% | Cowen & Co. | Cai Rumohr | → $478 | Downgrade | Outperform → Market Perform | Get Alert |
| 01/18/2023 | Buy Now | 5.81% | Wells Fargo | Matthew Akers | $575 → $460 | Maintains | Equal-Weight | Get Alert |
| 01/17/2023 | Buy Now | 15.01% | Cowen & Co. | Cai Rumohr | $570 → $500 | Maintains | Outperform | Get Alert |
| 01/13/2023 | Buy Now | -13.74% | Goldman Sachs | Noah Poponak | $440 → $375 | Downgrade | Neutral → Sell | Get Alert |
| 01/12/2023 | Buy Now | 24.22% | Credit Suisse | Scott Deuschle | $575 → $540 | Maintains | Outperform | Get Alert |
| 12/15/2022 | Buy Now | 44% | Morgan Stanley | Kristine Liwag | $585 → $626 | Maintains | Overweight | Get Alert |
| 12/08/2022 | Buy Now | 25.14% | Citigroup | Jason Gursky | → $544 | Initiates | → Neutral | Get Alert |
| 11/10/2022 | Buy Now | 34.57% | Morgan Stanley | Kristine Liwag | $530 → $585 | Maintains | Overweight | Get Alert |
| 10/28/2022 | Buy Now | 32.27% | RBC Capital | Ken Herbert | $550 → $575 | Maintains | Outperform | Get Alert |
| 10/28/2022 | Buy Now | 32.27% | Wells Fargo | Matthew Akers | $516 → $575 | Maintains | Equal-Weight | Get Alert |
| 10/14/2022 | Buy Now | — | JP Morgan | Seth Seifman | — | Downgrade | Overweight → Neutral | Get Alert |
| 10/12/2022 | Buy Now | 28.82% | Credit Suisse | Scott Deuschle | → $560 | Initiates | → Outperform | Get Alert |
| 10/11/2022 | Buy Now | 29.97% | Wolfe Research | Myles Walton | → $565 | Initiates | → Outperform | Get Alert |
| 09/28/2022 | Buy Now | 18.69% | Wells Fargo | Matthew Akers | $455 → $516 | Maintains | Equal-Weight | Get Alert |
| 08/31/2022 | Buy Now | 28.82% | Susquehanna | Charles Minervino | $530 → $560 | Maintains | Positive | Get Alert |
| 08/30/2022 | Buy Now | 26.52% | RBC Capital | Ken Herbert | → $550 | Initiates | → Outperform | Get Alert |
| 07/29/2022 | Buy Now | 21.91% | Susquehanna | Charles Minervino | $520 → $530 | Maintains | Positive | Get Alert |
| 07/29/2022 | Buy Now | 21.68% | Baird | Peter Arment | $488 → $529 | Upgrade | Neutral → Outperform | Get Alert |
| 07/12/2022 | Buy Now | 21.91% | Morgan Stanley | Kristine Liwag | $521 → $530 | Maintains | Overweight | Get Alert |
| 04/29/2022 | Buy Now | 10.87% | Wells Fargo | Matthew Akers | $472 → $482 | Maintains | Equal-Weight | Get Alert |
| 03/07/2022 | Buy Now | 8.57% | Wells Fargo | Matthew Akers | $390 → $472 | Maintains | Equal-Weight | Get Alert |
| 03/02/2022 | Buy Now | 19.84% | Morgan Stanley | Kristine Liwag | $428 → $521 | Maintains | Overweight | Get Alert |
| 01/28/2022 | Buy Now | -1.55% | Morgan Stanley | Kristine Liwag | $440 → $428 | Maintains | Overweight | Get Alert |
| 01/28/2022 | Buy Now | 0.52% | Susquehanna | Charles Minervino | $416 → $437 | Maintains | Positive | Get Alert |
| 01/11/2022 | Buy Now | — | Wolfe Research | Michael Maugeri | — | Downgrade | Outperform → Peer Perform | Get Alert |
| 01/10/2022 | Buy Now | — | Wells Fargo | Matthew Akers | — | Upgrade | Underweight → Equal-Weight | Get Alert |
| 01/05/2022 | Buy Now | -5.69% | Jefferies | Sheila Kahyaoglu | → $410 | Downgrade | Buy → Hold | Get Alert |
| 11/04/2021 | Buy Now | 1.21% | Morgan Stanley | Kristine Liwag | — | Maintains | Overweight | Get Alert |
| 10/29/2021 | Buy Now | — | Vertical Research | — | — | Downgrade | Buy → Hold | Get Alert |
| 09/23/2021 | Buy Now | -19.49% | Goldman Sachs | Noah Poponak | — | Upgrade | Sell → Neutral | Get Alert |
| 08/02/2021 | Buy Now | -22.94% | Wells Fargo | Matthew Akers | — | Maintains | Underweight | Get Alert |
| 07/19/2021 | Buy Now | -3.62% | Seaport Global | Richard Safran | — | Maintains | Buy | Get Alert |
FAQ
Northrop Grumman (NOC) 주식의 목표가는 얼마인가요?
Northrop Grumman (NYSE:NOC)의 최신 목표 주가는 6월 26, 2024에 BTIG에 의해 보고되었습니다. 이 애널리스트 기관은 $565.00에 대한 가격 목표를 설정했으며, 12개월 이내에 NOC이(가) rise될 것으로 예상합니다 (가능한 29.97% upside). 지난 1년간 21개의 애널리스트 기관이 평가를 보고했습니다.
Northrop Grumman (NOC)에 대한 가장 최근의 애널리스트 평가는 무엇인가요?
Northrop Grumman (NYSE:NOC)에 대한 최신 애널리스트 평가는 BTIG에 의해 제공되었으며, Northrop Grumman은(는) buy 평가를 시작했다합니다.
Northrop Grumman (NOC)에 대한 마지막 업그레이드는 언제 있었나요?
Northrop Grumman Corp에 대한 마지막 업그레이드는 4월 22, 2024에 발생했습니다. 이 때 Alembic Global는 N/A로 가격 목표를 올렸습니다. Alembic Global는 이전에 Northrop Grumman Corp에 대해 a neutral를 가지고 있었습니다.
Northrop Grumman (NOC)에 대한 마지막 다운그레이드는 언제 있었나요?
Northrop Grumman Corp에 대한 마지막 다운그레이드는 6월 21, 2024에 발생했습니다. 이 때 Bernstein가 Northrop Grumman Corp에 대해 가격 목표를 N/A에서 $477로 변경했습니다.
Northrop Grumman (NOC)에 대한 다음 애널리스트 평가는 언제 게시 또는 업데이트될 예정인가요?
애널리스트들은 주식 평가를 내리기 위해 철저한 연구를 진행합니다. 이 연구에는 공개된 재무 보고서를 검토하고, Northrop Grumman의 경영진 및 고객과 대화하며, 실적 회의 통화를 듣는 것이 포함됩니다. 대부분의 애널리스트들은 이를 매 분기마다 수행하므로, 한 해에는 회사당 애널리스트 당 4번의 평가를 받을 수 있습니다. Northrop Grumman에 대한 마지막 평가는 6월 26, 2024에 제출되었으므로, 다음 평가가 6월 26, 2025쯤에 제공될 것으로 예상됩니다.
애널리스트 평가 Northrop Grumman (NOC)가 올바른가요?
평가는 주관적이며 변할 수 있지만, 최신 Northrop Grumman (NOC) 평가는 시작했다로, 가격 목표는 $0.00에서 $565.00으로 조정되었습니다. 현재 Northrop Grumman (NOC)의 가격은 $434.73로, 이는 애널리스트의 예측 범위에서 within입니다.
검색 애널리스트 평가 및 가격 목표 모든 주식에 대한
사람들이 또한 지켜본다
© 2024 Benzinga | All Rights Reserved